National Cancer Institute
U.S. National Institutes of Health | www.cancer.gov

NCI Home
Cancer Topics
Clinical Trials
Cancer Statistics
Research & Funding
News
About NCI
Cancer Clinical Trials: A Resource Guide for Outreach, Education, and Advocacy



Introduction






Strategies for Outreach and Education






Ways to Educate Yourself






Ways to Educate Others, One-on-One






Ways to Conduct Community Outreach and Education






Ways to Work with the Media






Ways to Work with Hospitals, etc.






Appendix



Page Options
Print This Page
Print This Document
View Entire Document
E-Mail This Document
View/Print PDF
Quick Links
Director's Corner

Dictionary of Cancer Terms

NCI Drug Dictionary

Funding Opportunities

NCI Publications

Advisory Boards and Groups

Science Serving People

Español
NCI Highlights
Virtual and Standard Colonoscopy Both Accurate

Denosumab May Help Prevent Bone Loss

Past Highlights
Ways to Work with Hospitals, Medical Centers, and Universities

Work with Researchers and Health Care Professionals
Serve on an Institutional Review Board (IRB)

What You Can Do

  • Help researchers design and conduct clinical trial recruitment efforts

  • Find ways to get primary care doctors, oncologists, and oncology nurses to understand local clinical trial resources and to refer people to trials

  • Find out how you can serve on a local institutional review board (IRB)

Why?

To help increase access and accrual to cancer clinical trials

Introduction

Many public institutions recognize the importance of including nonscientists in the clinical trial review process and are including patients and advocates as members of advisory committees and planning/oversight groups that have a focus on clinical trials.

People from outside the research community play an important role in program planning and implementation, and help to set

Education and Outreach in Action

A retired mail carrier helped her significant other through cancer treatment. She read everything that she got her hands on about chemotherapy and learned a lot about cancer treatment.

Now that the cancer is in remission, she still logs onto the National Cancer Institute's Web site for new information. As a part of the local cancer support group, she attended a local cancer conference. One of the presenters discussed new medicine being studied in phase 3 trials, but mentioned in passing that the researchers are having trouble getting patients to consider participating in the trial.

During the "Q and A," she asked the presenter, "How can patient groups help you get the word out about this trial?" The group made a plan to meet with the researchers to figure out how they could work together.

Of the experience, the mail carrier says, "If I hadn't made contact at that meeting, they would still be having the same problems getting patients to consider participating in this trial. Experts don't realize the scope of patient organizations and all of the services we have to assist them with their trials and any other projects."

"I work in a breast cancer screening program," said a nurse from a Midwest health department. "Some women are really worried about getting breast cancer-they've lost a sister, a mother, an aunt to breast cancer. Once they've gotten a normal mammogram report, I tell them that they need to take care of themselves by getting annual mammograms and clinical breast exams, and I train them how to do breast self exams. But, I also tell them that they may want to think about participating in a breast cancer prevention trial." The health department works with local physicians, the local medical center, and some churches to let community members know about opportunities to participate in breast cancer prevention trials.

1. Work with Researchers and Health Care Professionals

In addition to sponsoring community forums and information sessions as outlined in other sections of this guide, many laypeople have worked alongside researchers to advise them in their clinical trial outreach and education efforts.

Points to keep in mind when assisting researchers with community outreach include the following:

  • Community members who are known, trusted, and accountable may be more effective and more believable to other community members than a researcher.

  • Community members can help advise researchers on ways to present clinical trial information that complements the values people in the community hold.

  • Community members can help foster the development of partnerships with organizations and the research institutions.

Tips to Find Out How You Can Help Researchers

Contact principal investigators or research nurses of local institutions. To find out the kind of research being conducted in your community:

  • Contact the research office of the institution.

  • Use the NCI Research Portfolio to find out about research going on in your community. The portfolio allows users to browse and explore active NCI-supported research, including extramural and intramural projects, by type of cancer or by type of cancer research. Research projects (including treatment, prevention, and cancer control studies) can also be sorted by research project title, principal investigator, State, and institution. Visit http://researchportfolio.cancer.gov.

For more information on strategies for clinical trial education and working with different ethnic/minority groups, see General Strategies for Educating Diverse Populations.

Tips to Find Out How You Can Help Health Care Professionals

Find ways to get primary care doctors, oncologists, and oncology nurses to understand local clinical trial resources and to refer people to trials:

  • Talk to your own primary care physician, oncologist and nurse about resources available to them from the NCI, such as:

    • The PDQ clinical trials registry. PDQ can be accessed by www.cancer.gov and through 1-800-4-CANCER.

    • The Cancer Information Service's Partnership Program. Through this program, the Cancer Information Service reaches the medically underserved, including minority groups and people with limited access to health information and services, with cancer information. The program can provide clinical trials training to state and regional organizations working with these populations. Call the Cancer Information Service at 1-800-4-CANCER or visit the National Cancer Institute's Web site at www.cancer.gov/cis.

    • The Cancer Trials Support Unit (CTSU). This is a pilot project sponsored by the National Cancer Institute (NCI) that supports a national network of physicians and patients to participate in NCI-sponsored phase III cancer treatment trials. For more information about joining, log on at www.ctsu.org or call 1-888-823-5923.

    • The NCI Research Portfolio.

  • Find an oncologist who can present information on clinical trials to primary care physicians and nurses in your community.

  • Contact local chapters of the American Academy of Family Physicians (www.aafp.org) and/or the Oncology Nurses Society (www.ons.org) to explore their knowledge of cancer clinical trials in your community.

Serve on an Institutional Review Board (IRB)

IRBs are made up of people who are qualified to evaluate new and ongoing clinical trials on the basis of scientific, legal, and ethical merit. The IRB determines whether the risks involved in a study are reasonable with respect to the potential benefits. IRBs also monitor the ongoing progress of the trial-from when it begins to when it ends.

Federal regulations require that each IRB is made up of at least five people; one member must be from outside the institution. IRBs usually are made up of a mix of medical specialists and lay members of the community. Many IRBs include members from diverse occupations and backgrounds.

In most cases, IRBs are located where the study is to take place. Most institutions that carry out clinical trials have their own IRBs.

Typical Questions Addressed by an IRB

  • Are the risks to participants minimized as much as possible through sound research design and the use of safety-focused procedures?

  • Are the risks reasonable in relation to the anticipated benefits and the importance of the knowledge that may result?

  • Are participants selected fairly?

  • Is a plan in place for seeking and documenting participants' informed consent?

  • Is the informed consent document both legally and ethically sound?

  • Have provisions been made for monitoring the data collected to ensure the safety of participants as the trial progresses?

  • Have provisions been made to protect the privacy of participants and the confidentiality of data collected during the study?

To find out how you can serve on an IRB:

  • To learn about vacancies, contact administrators (research or grant departments are good places to start) of local hospitals, cancer centers, or universities. Some may have waiting lists.

  • Ask your doctor or nurse.

To help you plan for work with hospitals, medical centers, and universities see the Plan for Action.

Back to Top

< Previous Section  |  Next Section >


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov